Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2012
05/17/2012US20120122962 Modified Small Interfering RNA Molecules and Methods of Use
05/17/2012US20120122959 Targeting MicroRNAs for Metabolic Disorders
05/17/2012US20120122954 Antisense Oligomers Targeting PCSK9
05/17/2012US20120122953 Methods for enhancing utrophin production via inhibition of microrna
05/17/2012US20120122943 Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents
05/17/2012US20120122937 Methods for inhibiting cancer cell proliferation and inducing cancer cell apoptosis
05/17/2012US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator
05/17/2012US20120122913 Combination of curcuminoids and mtor inhibitors for the treatment of tauopathies
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122830 Pregnenolone sulfate for the treatment of neurologic disorders
05/17/2012US20120122816 Compositions and methods for organ preservation
05/17/2012US20120122811 Bicyclic nucleosides and nucleotides as therapeutic agents
05/17/2012US20120122810 Fused Pentacyclic Polyethers
05/17/2012US20120122804 Substituted quinobenzoxazine analogs
05/17/2012US20120122801 Mannose-6-phosphate receptor mediated gene transfer into muscle cells
05/17/2012US20120122795 Accelerated extension of axons
05/17/2012US20120122770 Cell Cycle Arrest and Apoptosis
05/17/2012US20120122769 Antisense antibacterial compounds and methods
05/17/2012US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death
05/17/2012US20120122762 186 Human Secreted Proteins
05/17/2012US20120122760 Novel lipids for transfection of nucleic acids
05/17/2012US20120122718 BRM Expression and Related Diagnostics
05/17/2012US20120122716 Cell line derived from the epithelial lining of the human endolymphatic sac in the inner ear
05/17/2012US20120122686 Novel glyphosate-n-acetyltransferase (gat) genes
05/17/2012US20120122225 Carrier peptide fragment and use thereof
05/17/2012US20120122224 Device for performing photochemical processes
05/17/2012US20120122223 Mutated protoporphyrinogen ix oxidase (ppx) genes
05/17/2012US20120122222 Nanotopographic compositions and methods for cellular organization in tissue engineered structures
05/17/2012US20120122221 Culture medium and hydrophilic composite thereof
05/17/2012US20120122220 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
05/17/2012US20120122219 Porous composite biomaterials and production method of the same
05/17/2012US20120122218 Harnessing Cell Dynamics to Engineer Materials
05/17/2012US20120122217 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
05/17/2012US20120122216 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
05/17/2012US20120122215 Placental stem cell populations
05/17/2012US20120122214 Method for producing cell medicine
05/17/2012US20120122213 Method for culturing stem cells
05/17/2012US20120122212 Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
05/17/2012US20120122211 Generation of neural stem cells from undifferentiated human embryonic stem cells
05/17/2012US20120122210 Carrier peptide fragment and use thereof
05/17/2012US20120122209 Undifferentiated Stem Cell Culture Systems
05/17/2012US20120122208 Tubular Bioreactor System for Use in Bone and Cartilage Tissue Engineering
05/17/2012US20120122207 Method for Expanding Monocytes
05/17/2012US20120122206 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
05/17/2012US20120122204 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122184 Polypeptides of strain Bacillus sp. P203
05/17/2012US20120122182 Gaussia luciferase variant for high-throughput screening
05/17/2012US20120122181 Method for determining antagonist activity to a cytokinin receptor
05/17/2012US20120122177 Viral Infection Enhancing Peptide
05/17/2012US20120122156 Recombinant protein of fibroblast growth factor having adhesive activity for stem cells and method for culturing stem cells using the same
05/17/2012US20120122155 Immortalized avian cell lines and use thereof
05/17/2012US20120122150 Stabilization method for biological samples by combination of heating and chemical fixation
05/17/2012US20120122130 Coenzyme-Linked Glucose Dehydrogenase and Polynucleotide Encoding the Same
05/17/2012US20120122125 Anti-t. cruzi antibodies and methods of use
05/17/2012US20120122120 Antibodies against human epo receptor
05/17/2012US20120122118 Monclonal antibodies, hybridomas and methods for use
05/17/2012US20120122114 Immunoassay for the detection of procalcitonin
05/17/2012US20120122111 Rna sequence-specific mediators of rna interference
05/17/2012US20120122109 Neural progenitor cells derived from embryonic stem cells
05/17/2012US20120122073 Cis di-ahl modified controls for glycated hemoglobin s-a1c derived from healthy blood cells
05/17/2012US20120121713 Chimeric therapeutics, compositions, and methods for using same
05/17/2012US20120121712 Cellular electric stimulation mediated by piezoelectric nanotubes
05/17/2012US20120121697 Compositions and Methods for the Diagnosis and Treatment of Inflammatory Disorders and Fibrotic Disease
05/17/2012US20120121641 Mhc oligomer and method of making the same
05/17/2012US20120121637 Chimeric factor h binding proteins (fhbp) and methods of use
05/17/2012US20120121635 Expression in plants of HIV-related proteins
05/17/2012US20120121620 Anti-estrogen and immune modulator combinations for treating breast cancer
05/17/2012US20120121617 Promoters for recombinant viral expression
05/17/2012US20120121612 Fermented wheat germ proteins (fwgp) for the treatment of cancer
05/17/2012US20120121611 Method of treating autoimmune disease with mesenchymal stem cells
05/17/2012US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121596 Bispecific anti-her antibodies
05/17/2012US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
05/17/2012US20120121592 Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells
05/17/2012US20120121589 Modified egfr ectodomain
05/17/2012US20120121585 SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121583 Antibodies against human tweak and uses thereof
05/17/2012US20120121568 Superoxide dismutase variants and methods of use thereof
05/17/2012US20120121560 Methods of expanding and redifferentiating islet beta cells
05/17/2012US20120121558 Compositions and methods for treating plasma protein deficiency disorders
05/17/2012US20120121557 Neuregulin induced proliferation of cardiomyocytes
05/17/2012US20120121556 Methods of using regenerative cells to promote wound healing
05/17/2012US20120121555 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro
05/17/2012US20120121553 Selection and propagation of progenitor cells
05/17/2012US20120121552 Methods for purifying hematopoietic stem cells
05/17/2012US20120121550 Production of oligodendrocytes from placenta-derived stem cells
05/17/2012US20120121549 Induced pluripotent stem cells and methods of use
05/17/2012US20120121548 Production of reprogrammed pluripotent cells
05/17/2012US20120121546 Method of Producing Progenitor Cells from Differentiated Cells
05/17/2012US20120121544 Method for Efficiently Proliferating and Differentiating Natural Killer Cells from Umbilical Cord Blood
05/17/2012US20120121542 Red-shifted opsin molecules and uses thereof
05/17/2012US20120121538 Combined measles-malaria vaccine
05/17/2012US20120121537 Methods and Compositions for Inhibiting Hepatitis C Virus Replication
05/17/2012US20120121512 Monoclonal antibodies and their use
05/17/2012US20120121505 Therapeutic compositions and methods
05/17/2012US20120118811 Systems, methods and devices relating to a cellularized nephron unit
05/17/2012US20120118308 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
05/17/2012US20120117868 Sugarcane Centromere Sequences And Minichromosomes
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 1827